Morgan Stanley Opko Health, Inc. Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Opko Health, Inc. stock. As of the latest transaction made, Morgan Stanley holds 837,601 shares of OPK stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

837,601

Previous 2,059,054 59.32%

Holding current value

$1.07 Million

Previous $2.72 Million 52.23%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$1.19 - $1.55 $1.45 Million - $1.89 Million	-1,221,453 Reduced 59.32%	837,601 $1.3 Million
Q2 2025 Aug 15, 2025	SELL	$1.24 - $1.66 $2.54 Million - $3.4 Million	-2,049,434 Reduced 49.88%	2,059,054 $2.72 Million
Q1 2025 May 15, 2025	BUY	$1.45 - $1.94 $1.36 Million - $1.82 Million	940,546 Added 29.69%	4,108,488 $6.82 Million
Q4 2024 Feb 14, 2025	BUY	$1.4 - $1.64 $2.57 Million - $3.02 Million	1,838,554 Added 138.3%	3,167,942 $4.66 Million
Q3 2024 May 14, 2025	BUY	$1.21 - $1.68 $644,580 - $894,954	532,711 Added 66.87%	1,329,388 $1.98 Million

Q3 2024 Nov 14, 2024	BUY	$1.21 - $1.68 $644,580 - $894,954	532,711 Added 66.87%	1,329,388 $1.98 Million
Q2 2024 May 14, 2025	SELL	$1.21 - $1.42 $2.87 Million - $3.37 Million	-2,371,265 Reduced 74.85%	796,677 $995,000
Q2 2024 Oct 17, 2024	SELL	$1.21 - $1.42 $610,990 - $717,030	-504,951 Reduced 38.79%	796,677 $995,000
Q2 2024 Aug 14, 2024	SELL	$1.21 - $1.42 $610,990 - $717,030	-504,951 Reduced 38.79%	796,677 $995,000
Q1 2024 Oct 17, 2024	BUY	$0.87 - $1.57 $439,307 - $792,773	504,951 Added 63.38%	1,301,628 $1.56 Million
Q1 2024 Aug 16, 2024	SELL	$0.87 - $1.57 $494,782 - $892,882	-568,715 Reduced 30.41%	1,301,628 $1.56 Million
Q1 2024 May 15, 2024	SELL	$0.87 - $1.57 $494,782 - $892,882	-568,715 Reduced 30.41%	1,301,628 $1.56 Million
Q4 2023 Aug 16, 2024	BUY	$1.23 - $1.63 $1.32 Million - $1.75 Million	1,073,666 Added 134.77%	1,870,343 $2.82 Million
Q4 2023 Feb 13, 2024	BUY	$1.23 - $1.63 $530,428 - $702,926	431,243 Added 29.97%	1,870,343 $2.82 Million
Q3 2023 Nov 15, 2023	BUY	$1.5 - $2.17 $36,283 - $52,490	24,189 Added 1.71%	1,439,100 $2.3 Million
Q2 2023 Aug 14, 2023	BUY	$1.37 - $2.17 $40,990 - $64,926	29,920 Added 2.16%	1,414,911 $3.07 Million
Q1 2023 May 15, 2023	BUY	$1.06 - $1.61 $305,308 - $463,723	288,027 Added 26.26%	1,384,991 $2.02 Million
Q4 2022 Feb 14, 2023	SELL	$1.05 - $2.01 $263,492 - $504,399	-250,945 Reduced 18.62%	1,096,964 $1.37 Million
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.81 $26,489 - $41,124	-14,635 Reduced 1.07%	1,347,909 $2.55 Million
Q2 2022 Oct 27, 2022	SELL	$2.33 - $3.61 $2.93 Million - $4.55 Million	-1,259,030 Reduced 48.03%	1,362,544 $3.45 Million
Q2 2022 Aug 15, 2022	SELL	$2.33 - $3.61 $2.93 Million - $4.55 Million	-1,259,030 Reduced 48.03%	1,362,544 $3.45 Million
Q1 2022 Oct 27, 2022	BUY	$2.87 - $4.93 $3.61 Million - $6.21 Million	1,259,030 Added 92.4%	2,621,574 $9.02 Million
Q1 2022 May 13, 2022	BUY	$2.87 - $4.93 $5.05 Million - $8.68 Million	1,760,173 Added 204.34%	2,621,574 $9.02 Million
Q4 2021 Feb 14, 2022	SELL	$3.52 - $5.15 $923,873 - $1.35 Million	-262,464 Reduced 23.35%	861,401 $4.14 Million
Q3 2021 Nov 15, 2021	BUY	$3.44 - $4.24 $3.87 Million - $4.77 Million	1,123,865 New	1,123,865 $4.1 Million

Others Institutions Holding OPK

# of Institutions

256

Shares Held

195M

Call Options Held

1.68M

Put Options Held

126K

View Full List

About OPKO HEALTH, INC.

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $988M
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

More about OPK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account